8-K - Leap Therapeutics, Inc. | StockGist

Current Report Details

Event Type

Material Agreement

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

Entry into a Material Definitive Agreement. RSU Grant to Consultant As previously disclosed in a Current Report on Form 8-K filed with the U.S. Securities and E

Material Agreement

Source Document

1.02

Termination of a Material Definitive Agreement. The information set forth under Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference

Material Agreement

Source Document

9.01

Financial Statements and Exhibits. Exhibit No. Description 10.1 Restricted Stock Unit Grant Agreement, dated December 23, 2025, by and between the Company and C

Exhibits Only

Exhibits (2)

10.1

EXHIBIT 10.1

8-K

FORM 8-K